series-b
Stage
1
Investors
About
Genomic Vision develops proprietary molecular combing technology used for detailed genomic analysis to support quality control in bioproduction, gene and cell therapy, and drug discovery by providing single-molecule resolution of DNA replication and genetic modifications.
Explore Genomic Vision's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.